Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase in the United States

By sjmartinez • February 21, 2025

Pak K, Sachar R, Saab S. Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase in the United States. Dig Dis Sci. 2025 Feb 20. doi: 10.1007/s10620-025-08909-z. Epub ahead of print. PMID: 39979574.

Tags: Digestive Diseases, Gray zone, HCC, hepatitis B, Immune-tolerant, Publications

JPEN Journal Club 91. Choosing the population to study

Koretz RL. JPEN Journal Club 91. Choosing the population to study. JPEN J Parenter Enteral Nutr. 2025 Feb 19. doi: 10.1002/jpen.2737. Epub ahead of print.[...]

Restraint stress exacerbates indomethacin-induced gastric antral ulcers by gastroparesis via activation of corticotropin-releasing factor 2 receptors in refed mice

Satoh H, Akiba Y, Urushidani T, Kaunitz JD. Restraint stress exacerbates indomethacin-induced gastric antral ulcers by gastroparesis via activation of corticotropin-releasing factor 2 receptors in[...]

The microbiome as a modulator of neurological health across the maternal-offspring interface

Orchanian SB, Hsiao EY. The microbiome as a modulator of neurological health across the maternal-offspring interface. J Clin Invest. 2025 Feb 17;135(4):e184314. doi: 10.1172/JCI184314. PMID:[...]